MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions.   MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organization through the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.  Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.

Toronto Innovation Acceleration Partners

NuraLogix Corporation

At NuraLogix, we use Affective AI to improve the lives of people everywhere. Our patented technology, Transdermal Optical Imaging (TOI™), utilizes a conventional video camera to extract facial blood flow information from the human face in just 30 seconds! Anura™ is NuraLogix's TOI based app that uses allows contactless health tracking. Using only a smartphone, Anura™ is the world’s first app for contactless blood pressure measurement, without the need for a cuff or another wearable. Anura™ also measures other physiological, physical and psychological indexes, including heart rate, stress levels, BMI and cardiovascular disease risks with medical grade accuracy (based on research and clinical studies).

NuraLogix is a health technology AI company developing advanced emotion recognition software and biometric solutions. It uses AI and ML algorithms to interpret human emotions accurately, non-intrusively, and in real-time.&nbsp;

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

NuraLogix

NuraLogix Corporation on LinkedIn: #hltheurope #hlth #innovation #digitalhealth #medtech

NTT Data

NTT DATA begins offering vitals measurement service with a smartphone camera for commercial use in partnership with NuraLogix Corporation

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

NuraLogix is a health technology AI company developing advanced emotion recognition software and biometric solutions. It uses AI and ML algorithms to interpret human emotions accurately, non-intrusively, and in real-time.The company launched Anura Telehealth, a platform that performs continuous health and vital sign measurements during video calls. Unlike traditional wearables, it uses conventional video cameras to extract facial blood flow information and calculate over 30 medical vitals and health risk assessments, such heart rate, breathing rate, and cuffless blood pressure, along with risk assessments to identify and prevent chronic conditions like type 2 diabetes, hypertension, cardiovascular disease, and mental health, within an intuitive app. The company claims they have achieved contactless blood pressure measurement.The company operates a B2B2C business model offering services to patients via healthcare and insurance providers. The company’s solutions are applicable to several other industries including; education, gaming, market research and automotive.Key Customers and PartnershipsThe company has several key customers for its Anura telehealth platform, including NTT Data, Bupa Group, HSBC, AIA, and FWD.In addition, the company has several key partnerships such as telepass and Neocogita (in January 2023) to distribute Anura telehealth platform in Italy.

NuraLogix is a health technology AI company developing advanced emotion recognition software and biometric solutions. It uses AI and ML algorithms to interpret human emotions accurately, non-intrusively, and in real-time.&nbsp;The company’s flagship product, Anura, is an app that can measure over 100 health and wellness parameters using a conventional video camera and the company's patented Transdermal Optical Imaging (TOI) technique. TOI extracts facial blood flow information, which is then analyzed by advanced signal processing and machine learning AI algorithms on the cloud-based DeepAffex platform. In<a href="https://sp-edge.com/updates/25341"> January 2024</a>, the company introduced Anura MagicMirror, a smart mirror device that can analyze and assess vital health signs derived from a person's facial blood flow, at CES 2024.&nbsp;In November 2023, NuraLogix commercially deployed Anura Telehealth, enabling real-time assessment of vital signs during video consultations with physicians. The company operates a B2B2C business model offering services to patients via healthcare and insurance providers. The company’s solutions are applicable to several other industries including; education, gaming, market research and automotive.&nbsp;&nbsp;Key customers and partnershipsThe company has several key customers for its Anura telehealth platform, including NTT Data, Bupa Group, HSBC, AIA, and FWD.&nbsp;In addition, the company has several key partnerships such as telepass and Neocogita (in January 2023) to distribute Anura telehealth platform in Italy. Further, in May 2022, NuraLogix partnered with LaFiya Telehealth to integrate Anura into their platform, enabling patients to receive instant medical-grade health and wellness measurements after a 30-second video selfie.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

PROMINENT_CATEGORY

<div>
 Health tech AI company NuraLogix has just unveiled Anura MagicMirror at CES 2024, a smart mirror capable of analyzing vital health signs from a person's facial blood flow. This launch comes on the heels of the company's November 2023 release of Anura Telehealth, which provides health measurements during video calls.
 Employing patented Transdermal Optical Imaging technology, the new device gathers facial blood flow information to measure over 100 health parameters. The data is then processed by the cloud-based DeepAffex platform. The company asserts that Anura MagicMirror delivers fast and accurate health assessments, easing the workload on health professionals.
 
</div>

NuraLogix

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless